Form 8-K - Current report:
SEC Accession No. 0001193125-25-288343
Filing Date
2025-11-19
Accepted
2025-11-19 17:20:43
Documents
15
Period of Report
2025-11-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d46182d8k.htm   iXBRL 8-K 30460
2 EX-1.1 d46182dex11.htm EX-1.1 201277
3 EX-5.1 d46182dex51.htm EX-5.1 8539
7 GRAPHIC g46182dsp05.jpg GRAPHIC 5799
  Complete submission text file 0001193125-25-288343.txt   418869

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA olma-20251119.xsd EX-101.SCH 2831
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE olma-20251119_lab.xml EX-101.LAB 17234
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE olma-20251119_pre.xml EX-101.PRE 10799
17 EXTRACTED XBRL INSTANCE DOCUMENT d46182d8k_htm.xml XML 3508
Mailing Address 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address 780 BRANNAN STREET SAN FRANCISCO CA 94103 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39712 | Film No.: 251500259
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)